Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03644589 | Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer | withdrawn | Phase 2 | 0 | University of WashingtonOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT03158441 | DTi Diffusion Findings in Breast MRI Screening and Diagnostic | withdrawn | — | 0 | Rabin Medical CenterOTHER | 0 | Apr 23, 2019 | clinicaltrials |
| NCT03058939 |
| Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer |
| withdrawn |
| Phase 2 |
| 0 |
| University of ChicagoOTHER |
| 1 |
| Apr 22, 2019 |
| clinicaltrials |
| NCT02324894 | Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound. | withdrawn | N/A | 0 | Brugmann University HospitalOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT02610920 | Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection | withdrawn | Early Phase 1 | 0 | Columbia UniversityOTHER | 0 | Mar 26, 2019 | clinicaltrials |
| NCT02574546 | Markers for Predicting Risk of Breast Cancer in Women of Different Races | withdrawn | — | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03127332 | Metastatic Breast Cancer Treatment Planning | withdrawn | N/A | 0 | Carevive Systems, Inc.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03238703 | Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer | withdrawn | Phase 4 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 27, 2018 | clinicaltrials |
| NCT03388814 | Speeding Recovery From Pain and Opioid Use | withdrawn | Early Phase 1 | 0 | Wake Forest University Health SciencesOTHER | 0 | Nov 30, 2018 | clinicaltrials |
| NCT02470819 | Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer | withdrawn | N/A | 0 | Avera McKennan Hospital & University Health CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT03616457 | Automated Breast Ultrasound as an Adjunct to Screening Digital Breast Tomosynthesis(AMELIA) | withdrawn | — | 0 | GE HealthcareINDUSTRY | 0 | Oct 26, 2018 | clinicaltrials |
| NCT02988648 | A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter | withdrawn | Phase 1 / Phase 2 | 0 | Yale UniversityOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03285607 | MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Aug 16, 2018 | clinicaltrials |
| NCT02372305 | Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery | withdrawn | Phase 4 | 0 | University of ArkansasOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT03326258 | Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 18, 2018 | clinicaltrials |
| NCT02168179 | KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT03045393 | Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC(IMGN853) | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT02331212 | Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer | withdrawn | — | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT01542203 | Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer | withdrawn | — | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01134497 | Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer(PLANET) | withdrawn | Phase 2 | 0 | Cardiff UniversityOTHER | 1 | May 22, 2018 | clinicaltrials |
| NCT00006123 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Beth Israel Deaconess Medical CenterOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT02505698 | A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment | withdrawn | — | 0 | Real Imaging Ltd.INDUSTRY | 1 | Apr 11, 2018 | clinicaltrials |
| NCT02103946 | Serratus Anterior Plane Block Versus Paravertebral Block for Postmastectomy Analgesia(SAM) | withdrawn | N/A | 0 | National Cancer Institute, EgyptOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT00328354 | Mammography SPECT With Rotating Slant Hole Collimator | withdrawn | — | 0 | Johns Hopkins UniversityOTHER | 1 | Apr 6, 2018 | clinicaltrials |
| NCT01796444 | Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node(Z0011-China) | withdrawn | Phase 3 | 0 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02269696 | The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients | withdrawn | Phase 3 | 0 | Kuopio University HospitalOTHER | 0 | Mar 22, 2018 | clinicaltrials |
| NCT03081234 | Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer(EarLEE-2) | withdrawn | Phase 3 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Mar 15, 2018 | clinicaltrials |
| NCT01710293 | Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis(PACT CREATE 3) | withdrawn | N/A | 0 | VA Office of Research and DevelopmentFED | 1 | Feb 26, 2018 | clinicaltrials |
| NCT02784730 | Iterative PICC Placement Versus Long Term Device(PICC One Day) | withdrawn | Phase 3 | 0 | Centre Leon BerardOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00610831 | Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD) | withdrawn | N/A | 0 | University of California, IrvineOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03126487 | High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast Cancer(MRHEATBREAST) | withdrawn | N/A | 0 | Centre Antoine LacassagneOTHER | 1 | Jan 29, 2018 | clinicaltrials |
| NCT01972048 | Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening | withdrawn | N/A | 0 | University of MinnesotaOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT00615524 | Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer | withdrawn | Phase 2 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Jan 12, 2018 | clinicaltrials |
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | withdrawn | Phase 1 / Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Dec 13, 2017 | clinicaltrials |
| NCT00373152 | MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer | withdrawn | Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Dec 5, 2017 | clinicaltrials |
| NCT00855114 | Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery | withdrawn | Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT01724242 | Vaginal DHEA for Women After Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Hadassah Medical OrganizationOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT02752009 | Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy | withdrawn | N/A | 0 | Dana-Farber Cancer InstituteOTHER | 0 | Nov 21, 2017 | clinicaltrials |
| NCT02944721 | Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer(DOLORISKSEIN) | withdrawn | N/A | 0 | Hopital FochOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT00722683 | Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts | withdrawn | N/A | 0 | University of MichiganOTHER | 1 | Oct 18, 2017 | clinicaltrials |
| NCT03032614 | Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 0 | Oct 10, 2017 | clinicaltrials |
| NCT02768714 | Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy | withdrawn | Phase 3 | 0 | Eurofarma Laboratorios S.A.INDUSTRY | 0 | Sep 15, 2017 | clinicaltrials |
| NCT03080428 | Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer(OPTIGEN) | withdrawn | N/A | 0 | UNICANCEROTHER | 0 | Aug 28, 2017 | clinicaltrials |
| NCT01344109 | A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | withdrawn | — | 0 | Leo W. Jenkins Cancer CenterOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT00899145 | Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers | withdrawn | — | 0 | Gynecologic Oncology GroupNETWORK | 1 | Jul 13, 2017 | clinicaltrials |
| NCT02651610 | Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Peregrine PharmaceuticalsINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT01386502 | CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01936961 | Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors(I-CREST) | withdrawn | N/A | 0 | Western Regional Medical CenterOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT02915172 | Lenvatinib and Capecitabine in Patients With Advanced Malignancies | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jun 26, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Apr 26, 2019source: clinicaltrials